Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Black holes in multiple sclerosis : definition, evolution, and clinical correlations
JournalItem (Reviews, Editorials, Rezensionen, Urteilsanmerkungen etc. in einer wissenschaftlichen Zeitschrift)
 
ID 1197309
Author(s) Sahraian, M A; Radue, E-W; Haller, S; Kappos, L
Author(s) at UniBasel Kappos, Ludwig
Year 2010
Title Black holes in multiple sclerosis : definition, evolution, and clinical correlations
Journal Acta neurologica scandinavica
Volume 122
Number 1
Pages 1-8
Keywords black hole, hypointense lesion, magnetic resonance imaging, multiple sclerosis
Abstract Magnetic resonance imaging (MRI) is a sensitive paraclinical test for diagnosis and assessment of disease progression in multiple sclerosis (MS) and is often used to evaluate therapeutic efficacy. The formation of new T2-hyperintense MRI lesions is commonly used to measure disease activity, but lacks specificity because edema, inflammation, gliosis, and axonal loss all contribute to T2 lesion formation. As the role of neurodegeneration in the pathophysiology of MS has become more prominent, the formation and evolution of chronic or persistent Tl-hypointense lesions (black holes) have been used as markers of axonal loss and neuronal destruction to measure disease activity. Despite the use of various detection methods, including advanced imaging techniques such as magnetization transfer imaging and magnetic resonance spectroscopy, correlation of persistent black holes with clinical outcomes in patients with MS remains uncertain. Furthermore, although axonal loss and neuronal tissue destruction are known to contribute to irreversible disability in patients with MS, there are limited data on the effect of therapy on longitudinal change in Tl-hypointense lesion volume. Measurement of black holes in clinical studies may elucidate the underlying pathophysiology of MS and may be an additional method of evaluating therapeutic efficacy.
Publisher Munksgaard
ISSN/ISBN 0001-6314
edoc-URL http://edoc.unibas.ch/dok/A6007464
Full Text on edoc No
Digital Object Identifier DOI 10.1111/j.1600-0404.2009.01221.x
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/20003089
ISI-Number WOS:000278563800001
Document type (ISI) Journal Article, Review
 
   

MCSS v5.8 PRO. 0.338 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
03/05/2024